Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Operations (2023 - 2025)

Upstream Bio has reported Cash from Operations over the past 3 years, most recently at 30631000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 30631000.0 for Q4 2025, down 56.18% from a year ago — trailing twelve months through Dec 2025 was 133275000.0 (down 125.23% YoY), and the annual figure for FY2025 was 133275000.0, down 125.23%.
  • Cash from Operations for Q4 2025 was 30631000.0 at Upstream Bio, down from 22240000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for UPB hit a ceiling of 8036000.0 in Q2 2024 and a floor of 41165000.0 in Q1 2025.
  • Median Cash from Operations over the past 3 years was 19612000.0 (2024), compared with a mean of 23173000.0.
  • Biggest five-year swings in Cash from Operations: decreased 21.74% in 2024 and later crashed 388.29% in 2025.
  • Upstream Bio's Cash from Operations stood at 16110000.0 in 2023, then dropped by 21.74% to 19612000.0 in 2024, then crashed by 56.18% to 30631000.0 in 2025.
  • The last three reported values for Cash from Operations were 30631000.0 (Q4 2025), 22240000.0 (Q3 2025), and 39239000.0 (Q2 2025) per Business Quant data.